AIP
CEMI

Ameritas Investment Partners’s Chembio diagnostics, Inc. CEMI Stock Holding History

Ameritas Investment Partners’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,721
Closed -$6K – 3375
2021
Q1 		$6K Hold
1,721
– – ﹤0.01% 2994
2020
Q4 		$8K Hold
1,721
– – ﹤0.01% 2902
2020
Q3 		$8K Hold
1,721
– – ﹤0.01% 2852
2020
Q2 		$6K Buy
+1,721
New +$16.3K ﹤0.01% 2941

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TEE
Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ameritas Investment Partners's CEMI Position: Q2 2021 in Review

Ameritas Investment Partners sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2021, closing a stake of 1,721 shares — an estimated $6K sold.

Ameritas Investment Partners first reported a position in CEMI in Q2 2020 and held it in 4 quarters. The position peaked at $8K in Q4 2020. 60 funds tracked by Wall St. Rank hold CEMI as of Q2 2021.

  • Ameritas Investment Partners reported no remaining Chembio diagnostics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Partners sold 1,721 Chembio diagnostics, Inc. shares in Q2 2021, an estimated $6K.
  • Ameritas Investment Partners first reported a position in Chembio diagnostics, Inc. in Q2 2020 and held it in 4 quarters.
  • Ameritas Investment Partners's Chembio diagnostics, Inc. position peaked at $8K in Q4 2020.
  • 60 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.